A druggable genome screen identifies modifiers of α-synuclein levels via a tiered cross-species validation approach
Rousseaux, Maxime W.C., Vázquez-Vélez, Gabriel E., Al-Ramahi, Ismael, Jeong, Hyun-Hwan, Bajic, Aleksandar, Revelli, Jean-Pierre, Ye, Hui, Phan, Emily T., Deger, Jennifer M., Perez, Alma M., Kim, Ji-YoLanguage:
english
Journal:
The Journal of Neuroscience
DOI:
10.1523/JNEUROSCI.0254-18.2018
Date:
September, 2018
File:
PDF, 10.30 MB
english, 2018